"We're Doomed, We're Saved" with Andreas Horchler and Louise von Stechow – father and daughter, journalist and biologist, talking about the technologies of the biorevolution. Can genetic engineering, synthetic biology, and artificial intelligence save humanity from disease, climate change, and overpopulation, or are these technologies the first step towards its downfall? Content and Editing: Louise von Stechow and Andreas Horchler Disclaimer: Louise von Stechow, Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics but do not claim to give medical, investment, or life advice in the podcast. Learn more about the future of biotech in our podcasts and keynotes. Contact us here: scientific communication: https://science-tales.com/ Podcasts: https://www.podcon.de/ Image: Kelly Sikkema via Unsplash
https://science-tales.com/
We are doomed we are saved #17
CRISPR CAS – Life’s processing tool
Gene editing technology allows humans, for the first time, to change the code of life with a precise editing system offering the potential for curing genetic diseases. The gene editing field is moving with impressive speed: after the seminal paper on the technology was published in 2012, the Nobel Prize awarded for the technology in 2020, and the first therapy approved for treatment of blood diseases in 2023. In this episode of We’re doomed, we’re saved Andreas Horchler and Louise von Stechow, discuss the tremendous potential of the technology, but also its darker side – the high cost of the therapeutic applications and the potential for augmenting, altering, and redesigning human genomes.
Content and Editing: Louise von Stechow and Andreas Horchler
Disclaimer: Louise von Stechow, Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, investment or even life advice in the podcast.
Image: Vipul Jha- via Unsplash
References: https://www.mckinsey.com/industries/life-sciences/our-insights/the-bio-revolution-innovations-transforming-economies-societies-and-our-lives https://www.mckinsey.com/industries/life-sciences/our-insights/gene-therapy-coming-of-age-opportunities-and-challenges-to-getting-ahead https://endpts.com/vertex-looking-to-right-their-rd-ship-flashes-data-suggesting-their-sickle-cell-crispr-therapy-is-working/ https://www.nature.com/articles/d41586-023-03590-6 https://www.nature.com/articles/d41586-023-01389-z https://www.nytimes.com/2005/07/03/books/chapters/more-than-human.html https://sciencehistory.org/stories/magazine/the-death-of-jesse-gelsinger-20-years-later/ https://innovativegenomics.org/news/crispr-clinical-trials-2023/ https://answers.childrenshospital.org/crispr-gene-editing/ https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/approved-cellular-and-gene-therapy-products